SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-142277
Filing Date
2024-05-20
Accepted
2024-05-20 08:36:03
Documents
14
Period of Report
2024-05-20
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d821953d8k.htm   iXBRL 8-K 27697
  Complete submission text file 0001193125-24-142277.txt   193104

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA eftrw-20240520.xsd EX-101.SCH 4374
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE eftrw-20240520_def.xml EX-101.DEF 14154
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE eftrw-20240520_lab.xml EX-101.LAB 23591
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eftrw-20240520_pre.xml EX-101.PRE 15188
17 EXTRACTED XBRL INSTANCE DOCUMENT d821953d8k_htm.xml XML 6009
Mailing Address 142 NORTH CEDROS AVENUE, SUITE B SOLANA BEACH CA 92075
Business Address 142 NORTH CEDROS AVENUE, SUITE B SOLANA BEACH CA 92075 (858) 925-8215
eFFECTOR Therapeutics, Inc. (Filer) CIK: 0001828522 (see all company filings)

IRS No.: 853306396 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39866 | Film No.: 24962505
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)